Are Aimmune Shareholders Getting Enough in the Buyout?
The prize for Nestle in its acquisition of Aimmune Therapeutics is Palforzia, the world’s first treatment for a food allergy.
All Work
Chris Lange
What Akcea Shareholders Get in the Ionis Buyout
Akcea Therapeutics stock jumped on Monday after it was announced that Ionis Pharmaceuticals would be acquiring all of its outstanding shares.
Campbell Soup, CrowdStrike, Macy’s, Zoom Video and More Major Earnings Coming This Week
24/7 Wall St. has previewed some of the key companies expected to report results this week, including Broadcom, Macy's and Zoom Video.
Has HP Gotten Back on Track?
HP shares got a boost after it released fiscal third-quarter financial results that were lower year over year but better than expected.
Ulta Beauty Crushes Expectations for Q2
Ulta Beauty posted much better bottom-line results than expected, sending shares sharply higher Friday morning.
How Dell Managed to Pull Off a Win in Q2 Despite Huge Hurdles
Dell Technologies reported better than expected second-quarter results, sending shares to a new 52-week high.
Why a Top Analyst Sees Microsoft Winning Big With TikTok
The sale of TikTok has been highly contested, and Microsoft may have gained an edge in this fight, or at least one analyst thinks so.
Abercrombie & Fitch Is Another Retailer Shaking Off COVID-19
Abercrombie & Fitch reported better than expected quarterly results before the markets opened on Thursday, giving shares a boost.
Dollar Retail Chains Get What They Pay For With Earnings
Both Dollar General and Dollar Tree announced their most recent quarterly reports on Thursday morning. Which discount retailer had the better report?
Luxury May Be the Next Driver of Amazon’s Growth Ambitions
As the e-commerce giant looks to extend its reach into new markets, one analyst sees more upside for Amazon stock.
Are Analysts Growing Too Optimistic on Salesforce After Earnings?
Salesforce.com reported its most recent quarterly results after the markets closed on Tuesday. While results were incredibly positive, analysts juiced this stock and now it is going parabolic.
Why Fluidigm’s COVID-19 Saliva-Based Test Is a Huge Hit
Fluidigm made a splash with the markets on Wednesday morning after the company announced a critical update from the FDA in regards to its COVID-19 test.
Is Urban Outfitters the One Retailer Crushing This COVID-19 Quarter?
Urban Outfitters stock rallied early Wednesday after the retailer posted better than expected quarterly results late on Tuesday.
Major Biotechs Scare Off Short Sellers
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Major Semiconductors Send Short Sellers Running for Cover
The August 14 short interest data have been compared with the previous report, and short sellers shied away from most of these selected semiconductor stocks.
Does the Market Need Another Electric Vehicle Stock?
Battery-electric vehicle manufacturer Greenpower Motor Company has filed with the SEC regarding its initial public offering.
How Medtronic Crushed Its Q1
Medtronic reported better than expected quarterly results before the markets opened on Tuesday.
Can Sigma Labs Bring 3D Printing Back to Life?
Sigma Labs may not be a household name, but that could change now that the company has announced that it had been awarded a contract by Mitsubishi Heavy Industries
Are Palo Alto Networks’ Q4 Earnings Enough For Investors?
Palo Alto Networks, Inc. (NYSE: PANW | PANW Price Prediction) released fiscal fourth-quarter financial results after markets closed Monday. The firm said that it had $1.48 in earnings per share (EPS) and $950.4 million…
This Cancer Genetics Merger Could Be the Future for Biotechs
Cancer Genetics shares more than doubled on Monday after the company announced a merger with StemoniX.